ライフサイエンスコーパス: postpartum

1 d tuberculin skin test (TST) at delivery and postpartum.

2 regnancy vs 1438 fmol/punch (IQR: 1178,1919) postpartum.

3 d third trimesters of pregnancy and 3 months postpartum.

4 us thromboembolism (VTE) during pregnancy or postpartum.

5 Of these, 42 (62%) recovered QGIT positivity postpartum.

6 complications, and utilized more acute care postpartum.

7 cohort of 1035 women following up to 8 years postpartum.

8 22.3% within 5-10 years, and 38.5% >10 years postpartum.

9 roximately one-third lower in pregnancy than postpartum.

10 derived TCR repertoire expanded within 10 wk postpartum.

11 d with greater weight gain in the first 6 mo postpartum.

12 ose enrolled) remained in the study at 12 mo postpartum.

13 red questionnaire at enrollment and 6 months postpartum.

14 etween women who initiated IPT antepartum or postpartum.

15 and between 1%-2% of each infection outcome postpartum.

16 ilk content of 275 metabolites at 1 and 6 mo postpartum.

17 ncy and calcium placebo capsules during 6 mo postpartum.

18 5 to 10 years and 38,5% more than ten years postpartum.

19 [n = 31 (CG); no relaxation therapy] at 2 wk postpartum.

20 occurring from onset of labour until 42 days postpartum.

21 modern family planning method within 8 weeks postpartum.

22 persistent dilatation in later pregnancy or postpartum.

23 ion and are followed until delivery and once postpartum.

24 estation; weight retention was measured 2 mo postpartum.

25 ported 3 times during pregnancy and 6 months postpartum.

26 ss during pregnancy and reduce bone recovery postpartum.

27 anuary 2018, with follow-up until six months postpartum.

28 re shared by PE-CVS, and PE decidua obtained postpartum.

29 00 000, with a median follow-up of 7.5 years postpartum.

30 s per 100,000 live births) in the first year postpartum.

31 4%) groups wanted to have a child in 2 years postpartum.

32 20 weeks (OR 3.65; CI 1.40-9.47, P = 0.004) postpartum.

33 tion, and to continue DTG for only two weeks postpartum.

34 lar bone loss during pregnancy and bone gain postpartum.

35 o postpartum or for 3 mo beginning at 0.5 mo postpartum.

36 in the third trimester and at least 2 weeks postpartum.

37 disease in women pregnant or within 42 days postpartum.

38 (+/-4) weeks of pregnancy and 8 (+/-4) weeks postpartum.

39 scored scales administered in pregnancy and postpartum.

40 ns from the last menstrual period to 90 days postpartum.

41 35 kg/m2, n = 86) women between 0.5 and 9 mo postpartum.

42 gnancy in KT recipients, stratified in years postpartum.

43 a Mother's Milk Study (n = 99) at 1 and 6 mo postpartum.

44 er injury during pregnancy through 12 months postpartum.

45 uring the length of the pregnancy and 1 year postpartum.

46 ible effect on graft function within 2 years postpartum.

47 At 1 mo postpartum, 10 metabolites differed between overweight/o

48 eight equation was the most accurate at 3 mo postpartum (100% accuracy) and 9 mo postpartum (98% accu

49 spectively), and the Harris-Benedict at 9 mo postpartum (-17 kcal, -0.5%).

50 ng plasma samples from participants 6-9 week postpartum (171 incident T2D vs. 179 controls).

51 Most events occurred within the first month postpartum (35 of 50).

52 trapartum (69.9% versus 59.8%, p = 0.18), or postpartum (36.1% versus 29.9%, p = 0.49) complications

53 respiratory quotient in women at 3 and 9 mo postpartum (3M-PP, 9M-PP, respectively), and to examine

54 were more likely to breastfeed at 6-8 weeks postpartum (43.6%, n = 10,496 versus 34.5%, n = 13,556,

55 During the last menstrual period to 90 days postpartum, 56% of women with CHD had comprehensive echo

56 of delivery (53%) and during the first year postpartum (62%).

57 During pregnancy and the first year postpartum, 64% (n = 19,344) and 13% (n = 3,994) did not

58 uation predicting REEWBC was the DRI at 3 mo postpartum (-7 kcal, -0.1%; absolute and percentage bias

59 at 3 mo postpartum (100% accuracy) and 9 mo postpartum (98% accuracy), with the smallest limits of a

60 ed solids in addition to breast milk at 4 mo postpartum achieved both standing [acceleration factor (

61 Postpartum AD was defined as use of antidepressants and/

62 ofovir diphosphate 300mg) among pregnant and postpartum adolescent girls and young women (AGYW).

63 to guide PrEP adherence support in pregnant/postpartum African women.

64 on (garlic, carrot juice), and within 1-4 mo postpartum after repeated maternal ingestion (variety of

65 Linear mixed models were adjusted for postpartum age and infant sex.

66 ptide present in the plasma of healthy women postpartum and increased further in pregnancies complica

67 Despite improved mood postpartum and independent of breastfeeding status, moth

68 Maternal and infant outcomes up to 6 weeks postpartum and liver-related complications up to 1 year

69 id (IFA) during pregnancy and the first 3 mo postpartum and LNSs for the children from 6 to 24 mo (IF

70 1) LNSs during pregnancy and the first 6 mo postpartum and LNSs for the offspring from 6 to 24 mo (L

71 Breast milk at 1, 3, and 6 months postpartum and midnasal swabs during infant illness epis

72 ts and 43 healthy women during pregnancy and postpartum and performed multicolor flow cytometry in a

73 Reported overall postpartum and specific intrapartum and postpartum compl

74 d risk for breast cancer in the first decade postpartum and this window of adverse effect extends ove

75 ly basis during pregnancy and the first 6 mo postpartum and to their infants from age 6 to 18 mo (LNS

76 , and nearly all declined between 2 and 5 mo postpartum and were not associated substantially with mi

77 e tests (OGTTs) at study baseline (6-9 weeks postpartum) and annually thereafter for 2 years, and we

78 ncy, and at 9 weeks, 14 months and 3.5 years postpartum, and frequency of infant stroking at 9 weeks.

79 Breast milk was sampled ~1 mo postpartum, and tetrahydrofolate (THF), 5-methyl-THF, 5-

80 ion and outpatient visit rates by pregnancy, postpartum, and trimester status.

81 atty acids and beta-hydroxybutyrate than mid-postpartum animals and control heifers.

82 g to the Mount Sinai Health System for their postpartum appointment between January 2, 2020 and June

83 Pregnancy and postpartum are high-risk periods for different forms of

84 3-15 days postpartum), which waned with time postpartum as transplacental dolutegravir cleared.

85 At 5 mo postpartum, associations between maternal micronutrient

86 recruited 244 PPCM patients (median 7 months postpartum) at 14 sites in Nigeria and applied structure

87 We define these cases as postpartum BC (PPBC) and propose that the unique biology

88 a (AOR = 0.35, 95% CI 0.19-0.67; p = 0.001), postpartum bleeding (AOR = 0.37, 95% CI 0.15-0.92; p = 0

89 e followed, these women are still at risk of postpartum bleeding.

90 cterization of cancer cells in pregnancy and postpartum breast cancer can be exploited as a surveilla

91 the prevention and/or improved treatment of postpartum breast cancer.

92 tion and therapeutic screening for pregnancy/postpartum breast cancers.

93 tations have been found across pregnancy and postpartum, but little is known about the long-term effe

94 A 49-year-old woman with SCT (HbS 38%) with postpartum cardiomyopathy underwent cardiac transplantat

95 crucial gap in understanding the quality of postpartum care for women giving birth in health facilit

96 Postpartum care has the potential to avert a substantial

97 h facility-based childbirth and good-quality postpartum care in SSA is critical to addressing stallin

98 ally reflect the lack of importance given to postpartum care in the global discourse on essential int

99 r care for twins spanning ante-, intra-, and postpartum care that typically should be offered during

100 stimated the percentage of women receiving a postpartum check by a health professional while in the c

101 The suboptimal levels of postpartum checks in health facilities in many of the in

102 call of the provider, timing, and receipt of postpartum checks.

103 to account the timing of TMA in pregnancy or postpartum, coexisting symptoms, first-line laboratory w

104 t or below their prepregnancy weight at 2 mo postpartum compared with 12.5% in the UC group (P = 0.05

105 d prevalence of antepartum, intrapartum, and postpartum complications among recently delivered women

106 ecific reported antepartum, intrapartum, and postpartum complications between study groups using hier

107 Reported postpartum complications were significantly lower among

108 rall postpartum and specific intrapartum and postpartum complications were significantly lower for wo

109 g voucher program appeared to increase early postpartum contraceptive uptake and continuation in a se

110 ily planning voucher, inclusive of immediate postpartum counseling, on uptake, early initiation, and

111 Early-postpartum cows were metabolically deficient with a sign

112 classified as immediate "postpartum" (median postpartum day=1; range 0-3).

113 Only within 2 years postpartum Delta SCr was marginally higher (0.18 mg/dL,

114 Only within 2 years postpartum, Delta SCr was marginally higher (0.18 mg/dL,

115 Postpartum depression (PPD) is associated with abnormali

116 n between OXTR rs53576 genotype and maternal postpartum depression on externalising problems in child

117 This is likely the cause of postpartum depression prevalent in ~12% of childbearing

118 depression was assessed using the Edinburgh Postpartum Depression Scale (EPDS; cut-off score 9).

119 Postpartum depression was assessed using the Edinburgh P

120 Maternal postpartum depression was measured using the Edinburgh P

121 with an environmental burden (i.e. maternal postpartum depression) may be one of the potential eleme

122 tween the OXTR rs53576 genotype and maternal postpartum depression, as an environmental risk, on beha

123 Postpartum depression, the most common complication of c

124 osed to environmental risks such as maternal postpartum depression, to facilitate the provision of ap

125 ntal tract and the cingulum, controlling for postpartum depression.

126 No associations were seen with postpartum depressive symptoms (7% of women) or with any

127 ere not uniformly distinguishable from early postpartum diagnoses.

128 pathways, leading to the adverse effect of a postpartum diagnosis.

129 Postpartum, direct oral anticoagulants are an option if

130 Clinical and rodent work suggests that this postpartum drop in estrogen results in an estrogen withd

131 ometrial homeostasis, tumor suppression, and postpartum endometrial regeneration.

132 tile males, indicating that TGFbeta-mediated postpartum endometrial repair is critical for endometria

133 cluding preterm delivery, early miscarriage, postpartum endometritis, and low birth weight.

134 Profiling postpartum energy metabolism may assist in optimizing we

135 el organism in which to model the effects of postpartum estrogen withdrawal on the brain and anxiety-

136 and then withdrawn from estrogen to simulate postpartum estrogen withdrawal.

137 nning initiation at 12, 14, 16, and 20 weeks postpartum, family planning discontinuation and/or chang

138 By 8 weeks postpartum, family planning was initiated in 144 (91%) p

139 pressive behavior in sexually naive and late postpartum female mice respectively, with no effect on s

140 y with collateral vessels in the pelvis in a postpartum female.

141 OR = 0.37, 95% CI 0.15-0.92; p = 0.033), and postpartum fever/infection (AOR = 0.27, 95% CI 0.11-0.65

142 ver, most clinical guidelines only recommend postpartum follow-up of those with a history of preeclam

143 6, and 36 wk of pregnancy and at 4 and 12 mo postpartum for serum 25-hydroxyvitamin D and markers of

144 1 studies of infection in women in labour or postpartum from 46 countries.

145 mic landscape of fetal and placental tissues postpartum from both IVF and naturally conceived childre

146 (n = 159), 2 mo (n = 131), and 6 mo (n = 94) postpartum from normal weight (NW, BMI = 18.5-24.9 kg/m2

147 trial disorders, as well as decidua obtained postpartum from women with sPE.

148 luated the association of delivery mode with postpartum gene expression using a cross-sectional study

149 cy group (14-24 weeks gestation, n=20) and a postpartum group (6-12 weeks postpartum, n=20) of AGYW a

150 The major causes of SMOs were postpartum haemorrhage and severe pre-eclampsia/eclampsi

151 Outcomes included cesarean section, postpartum haemorrhage, severe perineal tear, Apgar scor

152 llowing vaginal delivery is a major cause of postpartum haemorrhage.

153 mode of delivery, perineal lacerations, and postpartum haemorrhage.

154 stimated the percentage of women receiving a postpartum health check following childbirth in a health

155 d information is available on these mothers' postpartum health needs and access to services.

156 etal growth, preeclampsia, chorioamnionitis, postpartum hemorrhage, stillbirth, and infant malformati

157 Postpartum hepatitis C viral (HCV) load decline followed

158 By week 3, 5 infants with intra/postpartum HIV-infection (median HIV-RNA 1 160 000 copie

159 ted miRNAs expression profiles in first week postpartum HM exosomes from HIV-1 infected and uninfecte

160 bed placebo (7% vs 50%, P = .04) at 20 weeks postpartum in 1 very small RCT (n = 22 analyzed) but wit

161 nutrient intakes were assessed at 2 and 5 mo postpartum in 212 Indonesian lactating mother-infant pai

162 lowed-up during pregnancy and the first year postpartum in a population-based longitudinal demographi

163 chemotherapy or deferral of treatment until postpartum in selected patients can be considered, with

164 an underlying dyslipidemia during the early postpartum in those GDM women who progress to T2D and su

165 d during pregnancy may improve bone recovery postpartum in women consuming a typical US diet.

166 lating HCV-specific CD4+ T cells at 3 months postpartum in women with concurrent declines in viremia

167 k at any time in pregnancy and until 6 weeks postpartum in women with epilepsy on antiepileptic drugs

168 l illness risk between conception and 1 year postpartum in women with versus without diabetes and in

169 l illness risk between conception and 1 year postpartum in women with vs. without diabetes and in dia

170 53 stool samples, at 5, 13, 21, and 31 weeks postpartum (infants), and once at school age (6-11 years

171 RSFC and allopregnanolone is associated with postpartum intra-DMPFC connectivity.

172 Postpartum involution of the breast has been identified

173 TTP and aHUS associated with pregnancy, and postpartum, is paramount as both require urgent specific

174 imburse hospitals for provision of immediate postpartum long-acting reversible contraception (IPP-LAR

175 ) and propose that the unique biology of the postpartum mammary gland drives tumor progression.

176 e encounters from discharge through 12 weeks postpartum, maternal health needs, care access, and syst

177 rst dose and were reclassified as immediate "postpartum" (median postpartum day=1; range 0-3).

178 The observed differences in postpartum mood between patients of different SES in the

179 et for the treatment of major depression and postpartum mood disorders.

180 pandemic-related social restrictions on the postpartum mood of those living among different socioeco

181 Africa and their association with first-year postpartum mortality.

182 = 49), whereas TEE was measured once at 9 mo postpartum (n = 43) by whole body calorimetry (WBC).

183 easured at 3 mo postpartum (n = 52) and 9 mo postpartum (n = 49), whereas TEE was measured once at 9

184 REE was measured at 3 mo postpartum (n = 52) and 9 mo postpartum (n = 49), wherea

185 on, n=20) and a postpartum group (6-12 weeks postpartum, n=20) of AGYW aged 16-24 years in sub-Sahara

186 printed genes such as MEST and GNAS in early-postpartum oocytes suggest that early lactation metaboli

187 epigenetic regulation of metabolism in early-postpartum oocytes.

188 es for 1 mo beginning at 0.5, 1.5, or 2.5 mo postpartum or for 3 mo beginning at 0.5 mo postpartum.

189 (MMN) capsules during pregnancy through 6 mo postpartum or iron and folic acid (IFA) capsules during

190 he dilatation persists in later pregnancy or postpartum) or its characteristics (unilateral versus bi

191 regnancy vs 1406 fmol/punch (IQR:1053, 1859) postpartum (p=0.006).

192 All postpartum patients appearing to the Mount Sinai Health

193 specific health and social support needs of postpartum patients living in urban economic poverty.

194 A total of 516 postpartum patients were screened.

195 .5), with the heightened risk limited to the postpartum period (IRR, 5.5; 95% CI, 2.6-11.7).

196 rth) (epoch 1) with the frequency during the postpartum period (the following 7.5 months after pregna

197 ypothesize that metabolites during the early postpartum period accurately distinguish risk of progres

198 ion between PCP use during pregnancy and the postpartum period among 80 pregnant women and 55 infants

199 of singletons during the ante-, intra-, and postpartum period and computed neonatal mortality rates

200 physiology driving energy expenditure in the postpartum period is needed to better predict TEE and ul

201 Depression during pregnancy and the postpartum period is relatively common and can have adve

202 Risk of death was not limited to the early postpartum period targeted by most public health program

203 a distinct metabolic signature in the early postpartum period that predicted future T2D with a media

204 the transition from GDM to T2D in the early postpartum period that was superior to clinical paramete

205 istering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder.

206 hird, 4.8 [95% CI, 3.0-7.7]); the RR for the postpartum period was 0.7 (95% CI, 3.0-7.7).

207 of seizures during pregnancy than during the postpartum period was similar to that in women who were

208 .33 to 0.56); all deaths occurred during the postpartum period, and 4 were from liver failure (2 of t

209 etes onset, and is revealed during the early postpartum period, preceding progression to T2D, among w

210 During the postpartum period, the brain's inhibitory GABAA receptor

211 Pregnancy, specifically the postpartum period, was associated with hospitalization f

212 ad glucose tolerance tested during the early postpartum period.

213 ose their gestational weight gain during the postpartum period.

214 nning for treatment during pregnancy and the postpartum period.

215 to increase anxiety-like behavior during the postpartum period.

216 ry factors have not been examined during the postpartum period.

217 st common complications of pregnancy and the postpartum period.

218 ncy, although these did not persist into the postpartum period.

219 participants died during follow-up, 2 in the postpartum period.

220 ght regulation and its trajectory during the postpartum period.

221 ciated with initiation of therapy during the postpartum period.

222 ssment and risk factor management beyond the postpartum period.

223 ed women in this cohort presented during the postpartum period.

224 f lithium treatment during pregnancy and the postpartum period.

225 s at birth and remains suppressed during the postpartum period.

226 0.25-0.26), and they remained reduced during postpartum periods (odds ratios, 0.23-0.31).

227 hat clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinata

228 ts 18 years or older, including pregnant and postpartum persons, and adolescents aged 12 to 17 years

229 ored infant facial expressions at two months postpartum predicted infant motor system activity during

230 more effective than no lithium in preventing postpartum relapse (N=48, k=2; odds ratio=0.16, 95% CI=0

231 adiposity indices at 0.5 mo, 2 mo, and 6 mo postpartum, respectively.

232 s also a nonsignificant increase in maternal postpartum retention in the intervention periods.

233 Analysis of milk composition at 6 mo postpartum revealed 20 differentially abundant metabolit

234 GABA+/Cr concentrations are associated with postpartum RSFC and allopregnanolone is associated with

235 nt differences were observed between pre and postpartum SCr at longer follow-up intervals.

236 t differences were observed between pre- and postpartum SCr at longer follow-up intervals.

237 Accordingly, 32,990 early-postpartum-specific differentially methylated regions (D

238 etabolically-profiled cows at early- and mid-postpartum stages and characterized their epigenetic lan

239 in-mediated glucose uptake could be an early postpartum strategy to enhance lactation success in wome

240 ecent interpersonal violence, pre- and early postpartum stress, gestational age at birth, infant sex,

241 and tibial cortical BMD (P = 0.03) at 12 mo postpartum than the placebo group.

242 SUI and PD are common conditions in women postpartum that share some risk factors.

243 V-infected and 7 HIV-negative) at 4-16 weeks postpartum, then analyzed by genome assembly and novel m

244 nt women with cirrhosis during pregnancy and postpartum to optimize outcomes.

245 se from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of he

246 IL28B-CC genotype and 12-month postpartum undetectable viremia were the best predictors

247 094), we analyzed milk fatty acids at 3-4 mo postpartum using GLC.

248 with infant adiposity during the first 6 mo postpartum using untargeted metabolomics.

249 n to the risks of antepartum, peripartum and postpartum VTE are reported as odds ratios adjusted for

250 ood types have higher risk of antepartum and postpartum VTE, with odds ratios between 1.4 and 1.8.

251 d the rate of readmission from 30 to 90 days postpartum was 4.6%.

252 ogical investigations later in pregnancy and postpartum was challenging.

253 we found that milk microbiota at 3-4 months postpartum was dominated by inversely correlated Proteob

254 FAS but no dilatation in later pregnancy or postpartum, we did not find an association with hospital

255 ealth facilities in Tanzania at birth and at postpartum weeks 1, 2, 3, and 6 in HIV-exposed infants.

256 uble fiber was associated with a decrease in postpartum weight (beta: -0.82 kg; 95% CI: -1.35, -0.29

257 relation between maternal diet and change in postpartum weight after adjusting for maternal age, heig

258 er intake of added sugar was associated with postpartum weight gain (beta: 0.05; 95% CI: 0.004, 0.10;

259 0.002, 0.08; P = 0.04) were associated with postpartum weight gain.

260 umption of soluble fiber was associated with postpartum weight loss, which may partially offset the o

261 for future strategies to promote appropriate postpartum weight management.

262 he association between energy metabolism and postpartum weight retention (PPWR).

263 fiber intake were associated with changes in postpartum weight.

264 Corresponding numbers postpartum were 229 and 122 women.

265 and liver-related complications up to 1 year postpartum were evaluated by using multivariate log-bino

266 comparing 28 weeks of IPT antepartum versus postpartum, were tested by QuantiFERON-gold-in-tube (QGI

267 g maternal dolutegravir cessation (3-15 days postpartum), which waned with time postpartum as transpl

268 emala included 26 mother-infant dyads 4-6 mo postpartum who were randomly assigned to receive 3 treat

269 st cancer diagnosis during the 5- to 10-year postpartum window associates with high risk for subseque

270 ntent of HMOs and bioactive proteins at 6 mo postpartum with infant growth and motor and cognitive de

271 utrients during pregnancy and the first 6 mo postpartum, with no infant supplementation (non-LNS grou

272 7, 12) in pregnancy and 17 days (IQR:14, 21) postpartum, with steady-state achieved by five and eight

273 Enrolled postpartum WLWH completed an interviewer-administered qu

274 modern contraceptive methods among recently postpartum WLWH delivering at a publicly funded regional

275 Measuring energy expenditure for each postpartum woman is unfeasible; therefore, accurate pred

276 97%; specificity, 50% to 89%), pregnant and postpartum women (Edinburgh Postnatal Depression Scale:

277 invasive ventilation, in contrast to 95% of postpartum women (median gestational age at delivery 30

278 Further information on how mobile postpartum women access and remain in care would be inst

279 ing special populations such as pregnant and postpartum women and immunocompromised patients.

280 rovides nutritional support for pregnant and postpartum women and young children.

281 onavirus Disease 2019 (COVID-19) pandemic on postpartum women are of increasing concern among mental

282 inty that providing or referring pregnant or postpartum women at increased risk to counseling interve

283 hat in the second trimester of pregnancy and postpartum women did not show differences in their PPS s

284 Pregnant and postpartum women experienced higher rates of influenza-a

285 ial Organ Failure Assessment in pregnant and postpartum women in predicting severe maternal outcome.

286 icy specifically directed towards supporting postpartum women living in low SES by ameliorating some

287 nitiation appears frequently in pregnant and postpartum women living with human immunodeficiency viru

288 ions for perinatal depression in pregnant or postpartum women or their children.

289 ycemic clamp with stable isotopes, in 6-week postpartum women who were lactating (n = 12) or formula-

290 Among 86 pregnant and postpartum women with severe COVID-19 who received compa

291 Among postpartum women, 89% were extubated, 89% recovered, and

292 cases of invasive GBS disease in pregnant or postpartum women, and 57000 (UR, 12000-104000) fetal inf

293 ith anxiety disorders, including pregnant or postpartum women, and compared clinical outcomes and har

294 , including invasive disease in pregnant and postpartum women, fetal infection/stillbirth, and infant

295 ent decreased in 96% and 89% of pregnant and postpartum women, respectively.

296 th anxiety disorders, including pregnant and postpartum women.

297 ed outpatient visits were among pregnant and postpartum women.

298 tment and no treatment trials in pregnant or postpartum women.

299 (REE) and total energy expenditure (TEE) in postpartum women.

300 th anxiety disorders, including pregnant and postpartum women.